- Home
- MASK vs LSTA Comparison
MASK vs LSTA Comparison
Compare MASK & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MASK
- LSTA
- Stock Information
- Founded
- MASK 2017
- LSTA 1980
- Country
- MASK China
- LSTA United States
- Employees
- MASK N/A
- LSTA N/A
- Industry
- MASK
- LSTA Misc Health and Biotechnology Services
- Sector
- MASK
- LSTA Health Care
- Exchange
- MASK NYSE
- LSTA Nasdaq
- Market Cap
- MASK 37.7M
- LSTA 20.9M
- IPO Year
- MASK 2025
- LSTA N/A
- Fundamental
- Price
- MASK $2.20
- LSTA $2.87
- Analyst Decision
- MASK
- LSTA Strong Buy
- Analyst Count
- MASK 0
- LSTA 1
- Target Price
- MASK N/A
- LSTA $15.00
- AVG Volume (30 Days)
- MASK 83.3K
- LSTA 15.2K
- Earning Date
- MASK 01-01-0001
- LSTA 08-11-2025
- Dividend Yield
- MASK N/A
- LSTA N/A
- EPS Growth
- MASK 12.16
- LSTA N/A
- EPS
- MASK 0.19
- LSTA N/A
- Revenue
- MASK $4,718,055.00
- LSTA $1,000,000.00
- Revenue This Year
- MASK N/A
- LSTA N/A
- Revenue Next Year
- MASK N/A
- LSTA N/A
- P/E Ratio
- MASK $11.28
- LSTA N/A
- Revenue Growth
- MASK 7.89
- LSTA N/A
- 52 Week Low
- MASK $2.00
- LSTA $1.87
- 52 Week High
- MASK $4.19
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- MASK N/A
- LSTA 62.47
- Support Level
- MASK N/A
- LSTA $2.36
- Resistance Level
- MASK N/A
- LSTA $3.07
- Average True Range (ATR)
- MASK 0.00
- LSTA 0.21
- MACD
- MASK 0.00
- LSTA 0.04
- Stochastic Oscillator
- MASK 0.00
- LSTA 76.26
About MASK 3 E NETWORK TECHNOLOGY GROUP LTD
3 E Network Technology Group Ltd is a business-to-business (B2B) information technology (IT) business solutions provider. It focuses on integrated software and hardware solutions in the property management and exhibition services spaces and expanded software solutions offering to a variety of industries and sectors, including food establishments, real estate, exhibition & conferencing, and clean energy utilities. The business includes two main portfolios, namely the software development portfolio and exhibition and conference portfolio. Maximum revenue is generated from the software development portfolio.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.